Antineoplastons in Cancer Care | Burzynski Clinic
Jan 27, 2026 | By: Burzynski Clinic
The Importance of Cellular Balance in Cancer
Every cell in the body follows genetic instructions that regulate growth, repair, and death. In healthy cells, these instructions maintain balance. In cancer, this balance can be disrupted—genes that promote growth may stay active while protective genes are suppressed, allowing abnormal cells to multiply.
Research at the Burzynski Clinic in Houston, led by Dr. Stanislaw Burzynski, focuses on restoring proper cellular signaling. Antineoplastons, naturally occurring compounds in the body, help regulate gene expression and support a healthy cellular environment, aiming to influence abnormal cell behavior rather than simply attacking cells.
How Antineoplaston Therapy Works
Antineoplaston therapy targets the cellular and genetic imbalances that allow cancer to grow. Unlike conventional treatments that primarily kill cells, it helps cells communicate and regulate themselves, supporting healthy growth while controlling abnormal cells.
At the Burzynski Clinic, therapy is personalized for each patient using advanced testing to identify the mutations driving their cancer. Based on these insights, treatment combines Antineoplastons with targeted medications to address multiple cancer-related genes.
Antineoplastons may help by:
- Supporting normal gene expression
- Turning off cancer-driving genes
- Reinforcing the body’s natural defenses
Phenylbutyrate (PB), a key Antineoplaston medication, can target hundreds of mutated genes. Investigational ANP infusions are also available for advanced patients under the Texas Right to Try Law. Phase 2 clinical trials have shown long-term survival in some patients with advanced cancers, including brain tumors.
By focusing on precision rather than one-size-fits-all treatment, Antineoplaston therapy targets the specific drivers of each patient’s disease, improving effectiveness while minimizing unnecessary toxicity.
A Personalized, Patient-Centered Approach
Care at the Burzynski Clinic is tailored to each patient’s needs, considering personal health factors and the unique aspects of their cancer. The clinic emphasizes ongoing support, guidance, and coordination with other healthcare providers to ensure comfort and overall well-being.
By combining advanced insights with individualized attention, the clinic prioritizes quality of life, informed decision-making, and thoughtful, patient-centered care.
Staying at the Forefront of Oncology
Cancer care is constantly evolving, and the Burzynski Clinic stays ahead by combining the latest scientific insights with patient-centered care.
By exploring innovative approaches and refining techniques based on research and observation, the clinic delivers care that is both cutting-edge and compassionate, focusing on each patient’s comfort, support, and overall well-being.
Measuring Progress and Supporting Long-Term Health
Tracking progress is an essential part of effective cancer care. At the Burzynski Clinic, ongoing assessments guide therapy and ensure patient safety through regular evaluations.
Beyond treatment itself, the clinic supports overall wellness. Nutrition, immune function, and quality of life are emphasized to treat the whole person, not just the disease. This holistic focus reflects the belief that comprehensive care can meaningfully impact outcomes.
About Dr. Stanislaw Burzynski
Dr. Stanislaw Burzynski is a physician and researcher recognized worldwide for his pioneering work in cancer therapies. He graduated top of his class in medicine in Poland and earned a PhD, becoming one of the youngest physicians to hold both degrees in his country.
In the 1970s, he conducted research at Baylor College of Medicine in Houston, focusing on naturally occurring peptides and their potential role in controlling cancer. In 1977, he founded the Burzynski Clinic, which has since treated thousands of patients and conducted clinical trials on Antineoplastons, the compounds that grew out of his early research.
Dr. Burzynski has authored hundreds of scientific publications, holds numerous patents internationally, and collaborates with institutions around the world. He is also a member of several leading professional organizations in oncology and medical research.
Exploring Advanced Options in Cancer Care
For patients seeking alternatives to conventional cancer treatments, Antineoplaston therapy provides a biologically guided, research-driven approach. Under Dr. Burzynski, the clinic remains at the forefront of innovative oncology care.
If you or a loved one are exploring integrative cancer treatment options, learning more about Antineoplaston therapy may be an important step.
Schedule a consultation with the Burzynski Clinic in Houston, Texas, to discuss personalized treatment options and explore care designed for you.